Last reviewed · How we verify
Bacterial blepharitis
Approved treatments
- Zithromax · Pfizer Inc.
Macrolide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with an exceptionally long tissue half-life.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Bacterial blepharitis patent landscape — cliff calendar, originator estates, attackable patents
- Bacterial blepharitis treatment landscape brief
- Bacterial blepharitis treatment updates RSS
Frequently asked questions about Bacterial blepharitis
What drugs treat Bacterial blepharitis?
Tracked treatments include Zithromax.
What is the treatment for Bacterial blepharitis?
Standard treatment for Bacterial blepharitis includes Zithromax. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Bacterial blepharitis patent cliff · Bacterial blepharitis CI report
- Treatment: Zithromax · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing